Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Reinsurance Group of America (RGA) is a global life and health reinsurer providing risk transfer solutions to primary insurers across 26 countries, with significant operations in the U.S., Asia-Pacific, and EMEA. The company assumes mortality, morbidity, and longevity risks from insurers, earning spread income on invested premiums while managing actuarial risk through sophisticated underwriting and diversification across geographies and product lines. RGA's competitive position stems from its deep actuarial expertise, global scale enabling risk diversification, and strong relationships with primary insurers seeking capital relief and risk management solutions.
RGA earns revenue through three primary mechanisms: (1) underwriting spread by pricing reinsurance treaties above expected claims costs using proprietary mortality tables and actuarial models, (2) investment income spread by investing float from premiums received in fixed income portfolios yielding returns above crediting rates on liabilities, and (3) fee income from administrative services and financial structuring. Competitive advantages include global diversification reducing concentration risk, actuarial expertise enabling superior risk selection, and scale providing pricing power in treaty negotiations. The 6.5% operating margin reflects the capital-intensive nature and competitive pricing environment in reinsurance markets.
Mortality experience relative to pricing assumptions - favorable claims experience drives immediate earnings beats while adverse mortality (pandemics, excess deaths) creates reserve charges
Investment portfolio yields and credit spreads - spread compression or expansion directly impacts net investment income on $70B+ invested asset base
New business volume and pricing discipline - large treaty wins in Asia-Pacific or U.S. pension risk transfer deals signal growth, while pricing deterioration indicates competitive pressure
Regulatory capital requirements and solvency ratios - changes to RBC requirements or international capital standards (Solvency II, IFRS 17) affect capital deployment flexibility
Foreign exchange movements - significant Asia-Pacific and EMEA exposure creates translation risk, particularly USD strength reducing reported earnings from international operations
Pandemic and catastrophic mortality risk - COVID-19 resulted in billions in industry claims; future pandemics or excess mortality trends (cardiovascular, cancer) could generate reserve inadequacy and capital depletion beyond modeled tail risk scenarios
IFRS 17 and regulatory accounting changes - new international accounting standards effective 2023 altered earnings recognition patterns and capital calculations, creating volatility and potential competitive disadvantages for companies with legacy treaty structures
Longevity risk mispricing - pension risk transfer and annuity reinsurance exposed to systematic underestimation of life expectancy improvements, particularly if medical advances accelerate beyond actuarial assumptions
Disintermediation through insurtech and direct reinsurance - primary insurers developing in-house actuarial capabilities or accessing capital markets through insurance-linked securities (ILS) could reduce traditional reinsurance demand
Intense pricing competition from well-capitalized global reinsurers (Munich Re, Swiss Re, Hannover Re) and alternative capital sources driving margin compression, particularly in commoditized mortality reinsurance
Loss of key client relationships - top 10 clients likely represent 30-40% of premiums; treaty non-renewals or recaptures due to competitive bidding or client M&A create revenue volatility
Geographic concentration risk in mature markets - U.S. life reinsurance market consolidation and slower growth compared to emerging Asia-Pacific markets where local competitors have regulatory advantages
Investment portfolio credit risk - $70B+ invested assets with exposure to corporate credit, commercial mortgages, and structured securities vulnerable to credit cycle deterioration and recession-driven defaults
Regulatory capital volatility - risk-based capital (RBC) ratios fluctuate with equity market movements, interest rate changes, and mortality experience, potentially constraining capital deployment during stress periods
Foreign currency translation exposure - estimated 30-40% of earnings from non-USD operations creates reported earnings volatility from FX movements, particularly USD strength reducing translated profits
Modest leverage at 0.44 debt-to-equity is manageable but limits financial flexibility compared to unleveraged competitors; refinancing risk exists if credit markets tighten during capital needs
moderate - Life insurance demand shows modest correlation to GDP growth as employment drives group life sales and wealth accumulation increases individual policy purchases. Recessions reduce new business volumes but in-force premiums remain stable due to long-duration liabilities. Asset-intensive business (annuities, pension risk transfer) accelerates during economic uncertainty as plan sponsors seek to de-risk. Claims experience can deteriorate during severe recessions due to stress-related mortality, though this is secondary to pandemic or catastrophic events.
High positive sensitivity to rising interest rates through multiple channels: (1) investment portfolio yields increase on new money rates and floating rate securities, expanding net investment income spread by an estimated 15-25 basis points per 100bp rate increase, (2) discount rates on long-duration liabilities rise, reducing present value of reserves and freeing capital, (3) asset-liability duration matching improves profitability in spread-based products. Conversely, the prolonged low-rate environment from 2020-2022 compressed spreads and reduced embedded value. Current rising rate environment from 2022-2026 is structurally positive for reinsurer profitability.
Moderate credit exposure through investment portfolio concentrated in investment-grade corporate bonds (estimated 60-70% of fixed income), with credit spread widening creating mark-to-market losses in available-for-sale securities and potential impairments. Reinsurance counterparty credit risk exists but is mitigated through collateral agreements and letters of credit. Economic downturns increasing primary insurer financial stress could elevate recapture risk where ceding companies buy back profitable treaties, though contractual protections typically limit this exposure.
value - Current 1.1x price-to-book and depressed 6.1% ROE suggest deep value opportunity if profitability normalizes toward historical 12-14% operating ROE targets. The 73.7% FCF yield appears anomalous (likely data quality issue given insurance accounting) but strong cash generation attracts value investors seeking capital return through dividends and buybacks. Modest 1.1% one-year return indicates lack of momentum, appealing to contrarian value investors betting on reinsurance cycle improvement and interest rate tailwinds. Not a growth or dividend story given muted recent performance and cyclical earnings volatility.
moderate-to-high - Reinsurance stocks exhibit elevated volatility from quarterly earnings surprises driven by claims experience, catastrophic events, and reserve development. Investment portfolio mark-to-market accounting under IFRS 17 amplifies book value volatility. Estimated beta of 1.1-1.3 to broader financials sector reflects sensitivity to interest rates, credit spreads, and risk appetite. Single-quarter adverse mortality can drive 10-15% stock declines, while favorable experience and rate environment improvements generate sharp rallies.
